Beat Theodor Weber

USPTO Granted Patents = 24 (Patent Applications = 2)

CIPO Patents = 3

EPO Patents = 15 (Patent Applications = 18)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 67(Granted Patents)

Location History:

Gualala, CA (US) (2019)
Zofingen, CH (2002 - 2023)

Company Filing History:

6 out of 42

Siegfried Aktiengesellschaft

patents

4 out of 92

Acadia Pharmaceuticals Inc.

Contraf-nicotex-tobacco Gmbh

patents

6. 2 out of 2

Siegfried (nantong) Pharmaceuticals Co. Ltd.

Bial-portela Ca & S.a.

11. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11840515 - Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c (2023-12-12),

2. 11629161 - Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ß-d-glucopyranos-1-yl)-benzene, L-proline and water (2023-04-18),

3. 11407730 - Preparation of racemic nicotine by reaction of ethyl nicotinate with N-vinylpyrrolidone in the presence of an alcoholate base and subsequent process steps (2022-08-09),

4. 11279685 - Enantiomeric separation of racemic nicotine by addition of an O,O″-disubstituted tartaric acid enantiomer (2022-03-22),

5. 11225500 - Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene, L-proline and water (2022-01-18),

6. 10981871 - Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C (2021-04-20),

7. 10981870 - Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form (2021-04-20),

8. 10927122 - Synthesis of noroxymorphone (2021-02-23),

9. 10822304 - Process for the production of N-Boc-2-amino-3,3-dimethylbutyric acid (2020-11-03),

10. 10738058 - Method of manufacturing 4-chloro-7H-pyrrolo[2,3-D]pyrimidine (2020-08-11),

11. 10597363 - Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C (2020-03-24),

12. 10391091 - Method of manufacturing buprenorphine and analogues thereof from oripavine (2019-08-27),

13. 10329268 - Processes for preparing medicaments for the treatment of cardiovascular diseases and intermediates for use therein (2019-06-25),

14. 10035807 - Method of manufacturing stereoisomers of buprenorphine and analogues thereof (2018-07-31),

15. 9546177 - Synthesis of noroxymorphone from morphine (2017-01-17),

Title: Beat Theodor Weber: Innovator in Pharmaceutical Patents

Introduction

Beat Theodor Weber is a notable inventor based in Zofingen, Switzerland. With an impressive portfolio of 24 patents, he has made significant contributions to the field of pharmaceuticals. His work primarily focuses on the synthesis and preparation of complex compounds that are crucial in medical applications.

Latest Patents

Weber's latest patents involve advanced methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (pimavanserin), including its tartrate salt and polymorphic form. The patents disclose a detailed approach for synthesizing this compound by contacting specific intermediates to achieve the desired product and its corresponding salt. Additionally, he has described methods for synthesizing a co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ß-d-glucopyranos-1-yl)-benzene and L-proline. This innovation highlights Weber's expertise in creating complex chemical structures that have significant pharmaceutical relevance.

Career Highlights

Throughout his career, Beat Theodor Weber has worked with prestigious companies such as Siegfried Aktiengesellschaft and Acadia Pharmaceuticals Inc. His experiences at these organizations have allowed him to develop his innovative skills and contribute significantly to their research and development efforts.

Collaborations

Weber has collaborated with notable colleagues in the industry, including Marlon Carlos and Sagun Tandel. These partnerships have further enhanced the depth of his research and innovation, fostering an environment that encourages the development of groundbreaking pharmaceutical compounds.

Conclusion

Beat Theodor Weber stands out as a prominent inventor in the pharmaceutical sector. His extensive patent portfolio and collaborations underscore his commitment to advancing drug development through innovative methods and complex synthesis. As the industry continues to evolve, Weber's contributions will undoubtedly continue to play a crucial role in shaping the future of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.